UroGen Pharma Ltd.

Ownership Transactions Reported by 16 Insiders

Symbol
URGN on Nasdaq
Industry
Pharmaceutical Preparations
Location
9 Ha'ta'asiya St, Ra'anana, Israel

Insiders trading volume in the past year

UroGen Pharma Ltd. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ran Nussbaum Director $26.7M Oct 21, 2022
Mark Schoenberg Chief Medical Officer $2.85M -$381K -11.8% Sep 7, 2025
Jason D. Smith General Counsel $828K -$255K -23.6% Sep 7, 2025
Dong Kim Chief Financial Officer $494K Sep 9, 2024
Molly Henderson Chief Financial Officer $94.5K Jan 31, 2022
Chris Degnan Chief Financial Officer $38.4K -$37.1K -49.1% Oct 8, 2025
James A. Robinson Jr. Director Aug 26, 2025
Fred E. Cohen Director Aug 6, 2024
Shawn Tomasello Director Jun 7, 2021
Arie Belldegrun Director Aug 26, 2025
Cynthia M. Butitta Director Aug 26, 2025
Elizabeth Barrett Chief Executive Officer Jul 28, 2025
Stuart Holden Director Aug 26, 2025
Daniel George Wildman Director Aug 26, 2025
Kathryn E. Falberg Director Jun 7, 2021
Leana Wen Director Aug 26, 2025

Recent Insider Transactions by Companies or Individuals for UroGen Pharma Ltd.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.